Overview
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 30, 2026 | Genetic Analysis to attend DDW congress in Chicago | Genetic Analysis to attend DDW congress in Chicago Thu, Apr 30, 2026 10:00 CET Report this content OSLO, NORWAY, April 30, 2026: Microbiome DX company Genetic Analysis AS (“GA”) announces its attendance at Digestive Disease Week (DDW) congr... |
| Apr 25, 2026 | May events to ignite your VA job search | This May, the Department of Veterans Affairs (VA) is heading to four of the nation’s premier medical conferences—Digestive Disease Week (DDW), American Urological Association (AUA), American Psychiatric Association (APA), and American Socie... |
| Apr 21, 2026 | Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW) | Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) Findings emphasize clinical decision-... |
| Apr 28, 2025 | Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW) | Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of moderate-to-severe Crohn's disease and ulcera... |
| Mar 17, 2025 | HepQuant to Present at Key Liver Conferences to Highlight Applications of HepQuant DuO™ - a Quantitative Liver Health Test | HepQuant DuO is a minimally invasive blood test to quantify liver health and enable liver specialists to enhance patient management. Recent clinical data demonstrate how HepQuant DuO test results may be used to inform endoscopy screening de... |
| May 21, 2024 | New Analysis Finds Endoscopic Sleeve Gastroplasty More Cost Effective Than Lifestyle Modification for Weight Loss | True You Weight Loss A new study reveals that endoscopic sleeve gastroplasty (ESG) is significantly more cost-effective than lifestyle modifications for treating obesity. This real-world study underscores ESG's potential as a cost-efficient... |
| May 21, 2024 | ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis | Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2] Data from a post-hoc analysis of the LIBERTY... |
| May 17, 2024 | Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference | Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab The data underscores Celltrion's commitment to improving patient out... |
| May 17, 2024 | Aqilion to present results at scientific events | Aqilion to present results at scientific events Fri, May 17, 2024 11:05 CET Report this content AQILION AB (publ) will present updates on the Company's progress and scientific results at two different scientific conferences in May. The pres... |
Reviews 0
FAQ about Digestive Disease Week® (DDW®)
When was Digestive Disease Week® (DDW®) founded?
Digestive Disease Week® (DDW®) was founded in 1969.
What has the press written about Digestive Disease Week® (DDW®)?
Parsers VC has collected 17 articles mentioning Digestive Disease Week® (DDW®), among them “Genetic Analysis to attend DDW congress in Chicago” (Apr 30, 2026) and “May events to ignite your VA job search” (Apr 25, 2026).
Is Digestive Disease Week® (DDW®) still active?
Yes, Digestive Disease Week® (DDW®) is active; its latest activity on Parsers VC dates from Sep 30, 2026.